BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3314200)

  • 1. [Tumor markers as a means of cancer diagnosis--expectations and problems].
    von Broen B
    Z Gesamte Inn Med; 1987 Jul; 42(14):377-82. PubMed ID: 3314200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
    Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
    Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Limitation of clinical usefulness of tumor marker].
    Ishii M
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1139-45. PubMed ID: 7544963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum tumor markers.
    Perkins GL; Slater ED; Sanders GK; Prichard JG
    Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of CEA, TPA, GICA, CA 72.4, and CA 195 in the Diagnosis of primary colorectal cancer and at its relapse.
    Nicolini A; Caciagli M; Zampieri F; Ciampalini G; Carpi A; Spisni R; Colizzi C
    Cancer Detect Prev; 1995; 19(2):183-95. PubMed ID: 7750106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Blood tumor markers in patients with lung cancer].
    Bianco A; Marcatili P; D'Auria D; Sorrentino P; Zofra S
    Ann Ital Med Int; 1996; 11(2):114-8. PubMed ID: 8974436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of serum markers for prostate cancer.
    Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor markers. Their current diagnostic status].
    Kudlacek S
    Wien Med Wochenschr; 1988 May; 138(10):228-42. PubMed ID: 3043919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tetranectin: methodological and clinical studies.
    Høgdall CK
    APMIS Suppl; 1998; 86():1-31. PubMed ID: 9868384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
    Jiang XT; Tao HQ; Zou SC
    Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix.
    Carmignani CP; Hampton R; Sugarbaker CE; Chang D; Sugarbaker PH
    J Surg Oncol; 2004 Sep; 87(4):162-6. PubMed ID: 15334630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of cancer by tumor markers in the blood: a view to the future.
    Sell S
    Crit Rev Oncog; 1993; 4(4):419-33. PubMed ID: 8353141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum tumor markers in colorectal cancer staging, grading, and follow-up.
    Plebani M; De Paoli M; Basso D; Roveroni G; Giacomini A; Galeotti F; Corsini A
    J Surg Oncol; 1996 Aug; 62(4):239-44. PubMed ID: 8691835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tumor markers (advances and limits)].
    Gomes FR
    Acta Med Port; 1997 Jan; 10(1):75-80. PubMed ID: 9245182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.
    Sun Z; Fu X; Zhang L; Yang X; Liu F; Hu G
    Anticancer Res; 2004; 24(2C):1159-65. PubMed ID: 15154641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokeratin tumor markers in ovarian carcinoma: tissue polypeptide specific antigen (TPS) and M3/M21].
    Hefler L; Tempfer C; Häusler G; Heinzl H; Kainz C
    Wien Klin Wochenschr; 1998 Oct; 110(18):635-41. PubMed ID: 9816636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gastrointestinal cancer].
    Takahashi Y
    Gan To Kagaku Ryoho; 2004 Aug; 31(8):1275-9. PubMed ID: 15332558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of common seric tumor markers in patients with solid cancers.
    Gara S; Boussen H; Ghanem A; Guemira F
    Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tumor marker in ovarian cancer].
    Komai K; Nishida T
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.